Trials / Recruiting
RecruitingNCT07104201
Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Xijing Hospital of Digestive Diseases · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fenofibrate in Subjects with Primary Biliary Cholangitis (PBC)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fenofibrate | Fenofibrate 200mg |
Timeline
- Start date
- 2025-03-13
- Primary completion
- 2035-03-01
- Completion
- 2035-03-01
- First posted
- 2025-08-05
- Last updated
- 2025-08-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07104201. Inclusion in this directory is not an endorsement.